Leader
|
|
|
00000nz a2200037n 45 0 |
001
|
|
|
WKP|Q38324244
(VIAF cluster)
(Authority/Source Record)
|
003
|
|
|
WKP |
005
|
|
|
20241221010710.0 |
008
|
|
|
241221nneanz||abbn n and d |
035
|
|
|
‡a
(WKP)Q38324244
|
024
|
|
|
‡a
0000-0001-7082-4695
‡2
orcid
|
035
|
|
|
‡a
(OCoLC)Q38324244
|
100
|
0 |
|
‡a
Jesús Giraldo
‡c
chercheur
‡9
fr
|
375
|
|
|
‡a
1
‡2
iso5218
|
400
|
0 |
|
‡a
Jesús Giraldo
‡c
researcher
‡9
en
|
400
|
0 |
|
‡a
Jesús Giraldo
‡c
wetenschapper
‡9
nl
|
400
|
0 |
|
‡a
Jesús Giraldo
‡c
investigador
‡9
ast
|
400
|
0 |
|
‡a
Jesús Giraldo
‡c
ricercatore
‡9
it
|
400
|
0 |
|
‡a
Jesús Giraldo
‡c
investigador
‡9
es
|
670
|
|
|
‡a
Author's A Complementary Scale of Biased Agonism for Agonists with Differing Maximal Responses
|
670
|
|
|
‡a
Author's A genomewide screen for tolerance to cationic drugs reveals genes important for potassium homeostasis in Saccharomyces cerevisiae.
|
670
|
|
|
‡a
Author's A method for the quantification of biased signalling at constitutively active receptors
|
670
|
|
|
‡a
Author's A pH-dependent model of the activation mechanism of the histamine H2 receptor
|
670
|
|
|
‡a
Author's Adrenergic and purinergic components in bisected vas deferens from spontaneously hypertensive rats
|
670
|
|
|
‡a
Author's Advanced age increases chromosome structural abnormalities in human spermatozoa
|
670
|
|
|
‡a
Author's Agonist induction, conformational selection, and mutant receptors
|
670
|
|
|
‡a
Author's Allosteric control of an asymmetric transduction in a G protein-coupled receptor heterodimer.
|
670
|
|
|
‡a
Author's Alpha 1-adrenoceptor vasoconstriction in the tail artery during ageing
|
670
|
|
|
‡a
Author's An allosteric modulator to control endogenous G protein-coupled receptors with light.
|
670
|
|
|
‡a
Author's An operational model for GPCR homodimers and its application in the analysis of biased signaling.
|
670
|
|
|
‡a
Author's Analysis of agonism at functional prejunctional alpha 2-adrenoceptors of rat vas deferens using operational and null approaches.
|
670
|
|
|
‡a
Author's Analysis of positive and negative allosteric modulation in metabotropic glutamate receptors 4 and 5 with a dual ligand.
|
670
|
|
|
‡a
Author's Angiotensin II type 1/adenosine A 2A receptor oligomers: a novel target for tardive dyskinesia
|
670
|
|
|
‡a
Author's Artificial Intelligence: A Novel Approach for Drug Discovery
|
670
|
|
|
‡a
Author's Assessing receptor affinity for inverse agonists: Schild and Cheng-Prusoff methods revisited.
|
670
|
|
|
‡a
Author's Assessing the
|
670
|
|
|
‡a
Author's Assessing the (a)symmetry of concentration-effect curves: empirical versus mechanistic models.
|
670
|
|
|
‡a
Author's Can Adding Constitutive Receptor Activity Redefine Biased Signaling Quantification?
|
670
|
|
|
‡a
Author's Changes in electrophysiological properties in the prostatic portion of vas deferens from spontaneously hypertensive rats
|
670
|
|
|
‡a
Author's Characterization of the calcium-mediated response to alkaline stress in Saccharomyces cerevisiae.
|
670
|
|
|
‡a
Author's Chromosomal bands affected by acute oil exposure and DNA repair errors
|
670
|
|
|
‡a
Author's Chromosomal Instability in Amniocytes From Fetuses of Mothers Who Smoke
|
670
|
|
|
‡a
Author's Chronic 5-HT6 receptor modulation by E-6837 induces hypophagia and sustained weight loss in diet-induced obese rats
|
670
|
|
|
‡a
Author's Computational analysis of negative and positive allosteric modulator binding and function in metabotropic glutamate receptor 5
|
670
|
|
|
‡a
Author's Computational analysis of negative and positive allosteric modulator binding and function in metabotropic glutamate receptor 5 (in)activation
|
670
|
|
|
‡a
Author's Conformational analysis of GpA and GpAp in aqueous solution by molecular dynamics and statistical methods
|
670
|
|
|
‡a
Author's Correction: Optical control of pain in vivo with a photoactive mGlu5 receptor negative allosteric modulator
|
670
|
|
|
‡a
Author's Correction: Rational design of a peptide capture agent for CXCL8 based on a model of the CXCL8:CXCR1 complex
|
670
|
|
|
‡a
Author's Coupling of the guanosine glycosidic bond conformation and the ribonucleotide cleavage reaction: implications for barnase catalysis
|
670
|
|
|
‡a
Author's Distinct Dopamine D₂ Receptor Antagonists Differentially Impact D₂ Receptor Oligomerization
|
670
|
|
|
‡a
Author's Dynamical Correlations Reveal Allosteric Sites in G Protein-Coupled Receptors
|
670
|
|
|
‡a
Author's Ecophysiological significance of scale-dependent patterns in prokaryotic genomes unveiled by a combination of statistic and genometric analyses
|
670
|
|
|
‡a
Author's Empirical models and Hill coefficients.
|
670
|
|
|
‡a
Author's Enhanced noradrenergic transmission in the spontaneously hypertensive rat anococcygeus muscle
|
670
|
|
|
‡a
Author's Evaluation of Operational Models of Agonism and Allosterism at Receptors with Multiple Orthosteric Binding Sites
|
670
|
|
|
‡a
Author's Evidence for distinct antagonist-revealed functional states of 5-hydroxytryptamine
|
670
|
|
|
‡a
Author's Evidence for distinct antagonist-revealed functional states of 5-hydroxytryptamine(2A) receptor homodimers.
|
670
|
|
|
‡a
Author's Exploring the Activation Mechanism of the mGlu5 Transmembrane Domain
|
670
|
|
|
‡a
Author's Exploring the Active Conformation of Cyclohexane Carboxylate Positive Allosteric Modulators of the Type 4 Metabotropic Glutamate Receptor
|
670
|
|
|
‡a
Author's Follow-Up Genotoxic Study: Chromosome Damage Two and Six Years after Exposure to the Prestige Oil Spill
|
670
|
|
|
‡a
Author's GNAO1 encephalopathy: further delineation of a severe neurodevelopmental syndrome affecting females.
|
670
|
|
|
‡a
Author's Have many estimates of efficacy and affinity been misled? Revisiting the operational model of agonism
|
670
|
|
|
‡a
Author's Head circumference growth function as a marker of neurological impairment in a cohort of microcephalic infants and children
|
670
|
|
|
‡a
Author's Helix 3 acts as a conformational hinge in Class A GPCR activation: An analysis of interhelical interaction energies in crystal structures
|
670
|
|
|
‡a
Author's How inverse can a neutral antagonist be? Strategic questions after the rimonabant issue
|
670
|
|
|
‡a
Author's Illuminating Phenylazopyridines To Photoswitch Metabotropic Glutamate Receptors: From the Flask to the Animals
|
670
|
|
|
‡a
Author's Increased superoxide anion production by interleukin-1beta impairs nitric oxide-mediated relaxation in resistance arteries
|
670
|
|
|
‡a
Author's Insights into adenosine A2A receptor activation through cooperative modulation of agonist and allosteric lipid interactions
|
670
|
|
|
‡a
Author's Integrated synthetic, pharmacological, and computational investigation of cis-2-(3,5-dichlorophenylcarbamoyl)cyclohexanecarboxylic acid enantiomers as positive allosteric modulators of metabotropic glutamate receptor subtype 4.
|
670
|
|
|
‡a
Author's Label noise in subtype discrimination of class C G protein-coupled receptors: A systematic approach to the analysis of classification errors
|
670
|
|
|
‡a
Author's Mathematical modeling of G protein-coupled receptor function: what can we learn from empirical and mechanistic models?
|
670
|
|
|
‡a
Author's Mechanistic analysis of the function of agonists and allosteric modulators: reconciling two-state and operational models
|
670
|
|
|
‡a
Author's Modeling cooperativity effects in dimeric G protein-coupled receptors.
|
670
|
|
|
‡a
Author's Modeling the binding and function of metabotropic glutamate receptors.
|
670
|
|
|
‡a
Author's Modelling the changes due to the endothelium and hypertension in the alpha-adrenoreceptor-mediated responses of rat aorta.
|
670
|
|
|
‡a
Author's Multiple active receptor conformation, agonist efficacy and maximum effect of the system: the conformation-based operational model of agonism
|
670
|
|
|
‡a
Author's On the fitting of binding data when receptor dimerization is suspected
|
670
|
|
|
‡a
Author's Operational models of allosteric modulation: caution is needed
|
670
|
|
|
‡a
Author's Optical control of pain in vivo with a photoactive mGlu5 receptor negative allosteric modulator
|
670
|
|
|
‡a
Author's OptoGluNAM4.1, a Photoswitchable Allosteric Antagonist for Real-Time Control of mGlu4 Receptor Activity.
|
670
|
|
|
‡a
Author's Overlapping binding sites drive allosteric agonism and positive cooperativity in type 4 metabotropic glutamate receptors
|
670
|
|
|
‡a
Author's Paternal Age and Numerical Chromosome Abnormalities in Human Spermatozoa
|
670
|
|
|
‡a
Author's Persistence of Breakage in Specific Chromosome Bands 6 Years after Acute Exposure to Oil.
|
670
|
|
|
‡a
Author's Pharmacological evidence for a metabotropic glutamate receptor heterodimer in neuronal cells
|
670
|
|
|
‡a
Author's Positional isomers of bispyridine benzene derivatives induce efficacy changes on mGlu5 negative allosteric modulation.
|
670
|
|
|
‡a
Author's Preface
|
670
|
|
|
‡a
Author's Preface. In cells
|
670
|
|
|
‡a
Author's Quantifying conformational changes in GPCRs: glimpse of a common functional mechanism.
|
670
|
|
|
‡a
Author's Quantifying the allosteric interactions within a G-protein-coupled receptor heterodimer
|
670
|
|
|
‡a
Author's Rational design of a peptide capture agent for CXCL8 based on a model of the CXCL8:CXCR1 complex
|
670
|
|
|
‡a
Author's Reducing the n-gram feature space of class C GPCRs to subtype-discriminating patterns
|
670
|
|
|
‡a
Author's Representation Learning for Class C G Protein-Coupled Receptors Classification
|
670
|
|
|
‡a
Author's Revealing the Mechanism of Agonist-Mediated Cannabinoid Receptor 1 (CB1) Activation and Phospholipid-Mediated Allosteric Modulation
|
670
|
|
|
‡a
Author's Role of elastin in spontaneously hypertensive rat small mesenteric artery remodelling
|
670
|
|
|
‡a
Author's Selective Protonation of Acidic Residues Triggers Opsin Activation
|
670
|
|
|
‡a
Author's Shift in nucleotide conformational equilibrium contributes to increased rate of catalysis of GpAp versus GpA in barnase
|
670
|
|
|
‡a
Author's Shining Light on an mGlu5 Photoswitchable NAM: A Theoretical Perspective
|
670
|
|
|
‡a
Author's Statistics for the analysis of molecular dynamics simulations: providing P values for agonist-dependent GPCR activation
|
670
|
|
|
‡a
Author's Structural insights into positive and negative allosteric regulation of a G protein-coupled receptor through protein-lipid interactions.
|
670
|
|
|
‡a
Author's Synthesis toward Bivalent Ligands for the Dopamine D2 and Metabotropic Glutamate 5 Receptors
|
670
|
|
|
‡a
Author's Systematic Analysis of Primary Sequence Domain Segments for the Discrimination Between Class C GPCR Subtypes.
|
670
|
|
|
‡a
Author's Terminating evolutionary algorithms at their steady state
|
670
|
|
|
‡a
Author's Text mining and expert curation to develop a database on psychiatric diseases and their genes
|
670
|
|
|
‡a
Author's The asymmetric/symmetric activation of GPCR dimers as a possible mechanistic rationale for multiple signalling pathways.
|
670
|
|
|
‡a
Author's The catalytic power of enzymes: conformational selection or transition state stabilization?
|
670
|
|
|
‡a
Author's The effect of the molecular mechanism of G protein-coupled receptor activation on the process of signal transduction
|
670
|
|
|
‡a
Author's The influence of alignment-free sequence representations on the semi-supervised classification of class C G protein-coupled receptors: semi-supervised classification of class C GPCRs.
|
670
|
|
|
‡a
Author's The slope parameter and the receptor reserve
|
670
|
|
|
‡a
Author's The structure and activity of membrane receptors: computational simulation of histamine H2-receptor activation
|
670
|
|
|
‡a
Author's Transient middle cerebral artery occlusion causes different structural, mechanical, and myogenic alterations in normotensive and hypertensive rats
|
670
|
|
|
‡a
Author's Use of the operational model of agonism and [3H]prazosin binding to assess altered responsiveness of α1-adrenoceptors in the vas deferens of spontaneously hypertensive rat
|
670
|
|
|
‡a
Author's Using machine learning tools for protein database biocuration assistance
|
670
|
|
|
‡a
Author's মুখবন্ধ
|
670
|
|
|
‡a
wikidata authority control
‡u
https://viaf.org/processed/ISNI|0000000140182126
|
670
|
|
|
‡a
wikidata authority control
‡u
https://viaf.org/processed/BNE|XX822781
|
670
|
|
|
‡a
wikidata authority control
‡u
https://viaf.org/viaf/273555765
|
670
|
|
|
‡a
wikidata authority control
‡u
https://viaf.org/processed/NKC|osd2014849677
|
670
|
|
|
‡a
wikidata authority control
‡u
https://viaf.org/processed/LC|nb2011027688
|
670
|
|
|
‡a
wikidata authority control
‡u
https://viaf.org/processed/SUDOC|157716856
|
909
|
|
|
‡a
(orcid) 0000000170824695
‡9
1
|
912
|
|
|
‡a
preface
‡A
Preface
‡9
1
|
912
|
|
|
‡a
মখবনধ
‡A
মুখবন্ধ
‡9
1
|
919
|
|
|
‡a
useoftheoperationalmodelofagonismandprazosinbindingtoassessalteredresponsivenessofα1adrenoceptorsinthevasdeferensofspontaneouslyhypertensiverat
‡A
Use of the operational model of agonism and [3H]prazosin binding to assess altered responsiveness of α1-adrenoceptors in the vas deferens of spontaneously hypertensive rat
‡9
1
|
919
|
|
|
‡a
complementaryscaleofbiasedagonismforagonistswithdifferingmaximalresponses
‡A
A Complementary Scale of Biased Agonism for Agonists with Differing Maximal Responses
‡9
1
|
919
|
|
|
‡a
genomewidescreenfortolerancetocationicdrugsrevealsgenesimportantforpotassiumhomeostasisinsaccharomycescerevisiae
‡A
A genomewide screen for tolerance to cationic drugs reveals genes important for potassium homeostasis in Saccharomyces cerevisiae.
‡9
1
|
919
|
|
|
‡a
methodforthequantificationofbiasedsignallingatconstitutivelyactivereceptors
‡A
A method for the quantification of biased signalling at constitutively active receptors
‡9
1
|
919
|
|
|
‡a
phdependentmodeloftheactivationmechanismofthehistamineh2receptor
‡A
A pH-dependent model of the activation mechanism of the histamine H2 receptor
‡9
1
|
919
|
|
|
‡a
adrenergicandpurinergiccomponentsinbisectedvasdeferensfromspontaneouslyhypertensiverats
‡A
Adrenergic and purinergic components in bisected vas deferens from spontaneously hypertensive rats
‡9
1
|
919
|
|
|
‡a
advancedageincreaseschromosomestructuralabnormalitiesinhumanspermatozoa
‡A
Advanced age increases chromosome structural abnormalities in human spermatozoa
‡9
1
|
919
|
|
|
‡a
agonistinductionconformationalselectionandmutantreceptors
‡A
Agonist induction, conformational selection, and mutant receptors
‡9
1
|
919
|
|
|
‡a
allostericcontrolofanasymmetrictransductioninagproteincoupledreceptorheterodimer
‡A
Allosteric control of an asymmetric transduction in a G protein-coupled receptor heterodimer.
‡9
1
|
919
|
|
|
‡a
alpha1adrenoceptorvasoconstrictioninthetailarteryduringageing
‡A
Alpha 1-adrenoceptor vasoconstriction in the tail artery during ageing
‡9
1
|
919
|
|
|
‡a
allostericmodulatortocontrolendogenousgproteincoupledreceptorswithlight
‡A
An allosteric modulator to control endogenous G protein-coupled receptors with light.
‡9
1
|
919
|
|
|
‡a
operationalmodelforgpcrhomodimersanditsapplicationintheanalysisofbiasedsignaling
‡A
An operational model for GPCR homodimers and its application in the analysis of biased signaling.
‡9
1
|
919
|
|
|
‡a
analysisofagonismatfunctionalprejunctionalalpha2adrenoceptorsofratvasdeferensusingoperationalandnullapproaches
‡A
Analysis of agonism at functional prejunctional alpha 2-adrenoceptors of rat vas deferens using operational and null approaches.
‡9
1
|
919
|
|
|
‡a
analysisofpositiveandnegativeallostericmodulationinmetabotropicglutamatereceptors4and5withadualligand
‡A
Analysis of positive and negative allosteric modulation in metabotropic glutamate receptors 4 and 5 with a dual ligand.
‡9
1
|
919
|
|
|
‡a
angiotensin2type1adenosinea2areceptoroligomersanoveltargetfortardivedyskinesia
‡A
Angiotensin II type 1/adenosine A 2A receptor oligomers: a novel target for tardive dyskinesia
‡9
1
|
919
|
|
|
‡a
artificialintelligenceanovelapproachfordrugdiscovery
‡A
Artificial Intelligence: A Novel Approach for Drug Discovery
‡9
1
|
919
|
|
|
‡a
assessingreceptoraffinityforinverseagonistsschildandchengprusoffmethodsrevisited
‡A
Assessing receptor affinity for inverse agonists: Schild and Cheng-Prusoff methods revisited.
‡9
1
|
919
|
|
|
‡a
assessingthe
‡A
Assessing the
‡9
1
|
919
|
|
|
‡a
assessingtheasymmetryofconcentrationeffectcurvesempiricalversusmechanisticmodels
‡A
Assessing the (a)symmetry of concentration-effect curves: empirical versus mechanistic models.
‡9
1
|
919
|
|
|
‡a
canaddingconstitutivereceptoractivityredefinebiasedsignalingquantification
‡A
Can Adding Constitutive Receptor Activity Redefine Biased Signaling Quantification?
‡9
1
|
919
|
|
|
‡a
changesinelectrophysiologicalpropertiesintheprostaticportionofvasdeferensfromspontaneouslyhypertensiverats
‡A
Changes in electrophysiological properties in the prostatic portion of vas deferens from spontaneously hypertensive rats
‡9
1
|
919
|
|
|
‡a
characterizationofthecalciummediatedresponsetoalkalinestressinsaccharomycescerevisiae
‡A
Characterization of the calcium-mediated response to alkaline stress in Saccharomyces cerevisiae.
‡9
1
|
919
|
|
|
‡a
chromosomalbandsaffectedbyacuteoilexposureanddnarepairerrors
‡A
Chromosomal bands affected by acute oil exposure and DNA repair errors
‡9
1
|
919
|
|
|
‡a
chromosomalinstabilityinamniocytesfromfetusesofmotherswhosmoke
‡A
Chromosomal Instability in Amniocytes From Fetuses of Mothers Who Smoke
‡9
1
|
919
|
|
|
‡a
chronic5ht6receptormodulationbye6837induceshypophagiaandsustainedweightlossindietinducedobeserats
‡A
Chronic 5-HT6 receptor modulation by E-6837 induces hypophagia and sustained weight loss in diet-induced obese rats
‡9
1
|
919
|
|
|
‡a
computationalanalysisofnegativeandpositiveallostericmodulatorbindingandfunctioninmetabotropicglutamatereceptor5
‡A
Computational analysis of negative and positive allosteric modulator binding and function in metabotropic glutamate receptor 5
‡9
1
|
919
|
|
|
‡a
computationalanalysisofnegativeandpositiveallostericmodulatorbindingandfunctioninmetabotropicglutamatereceptor5inactivation
‡A
Computational analysis of negative and positive allosteric modulator binding and function in metabotropic glutamate receptor 5 (in)activation
‡9
1
|
919
|
|
|
‡a
conformationalanalysisofgpaandgpapinaqueoussolutionbymoleculardynamicsandstatisticalmethods
‡A
Conformational analysis of GpA and GpAp in aqueous solution by molecular dynamics and statistical methods
‡9
1
|
919
|
|
|
‡a
correctionopticalcontrolofpaininvivowithaphotoactivemglu5receptornegativeallostericmodulator
‡A
Correction: Optical control of pain in vivo with a photoactive mGlu5 receptor negative allosteric modulator
‡9
1
|
919
|
|
|
‡a
correctionrationaldesignofapeptidecaptureagentforcxcl8basedonamodelofthecxcl8cxcr1complex
‡A
Correction: Rational design of a peptide capture agent for CXCL8 based on a model of the CXCL8:CXCR1 complex
‡9
1
|
919
|
|
|
‡a
couplingoftheguanosineglycosidicbondconformationandtheribonucleotidecleavagereactionimplicationsforbarnasecatalysis
‡A
Coupling of the guanosine glycosidic bond conformation and the ribonucleotide cleavage reaction: implications for barnase catalysis
‡9
1
|
919
|
|
|
‡a
distinctdopamined2receptorantagonistsdifferentiallyimpactd2receptoroligomerization
‡A
Distinct Dopamine D₂ Receptor Antagonists Differentially Impact D₂ Receptor Oligomerization
‡9
1
|
919
|
|
|
‡a
dynamicalcorrelationsrevealallostericsitesingproteincoupledreceptors
‡A
Dynamical Correlations Reveal Allosteric Sites in G Protein-Coupled Receptors
‡9
1
|
919
|
|
|
‡a
ecophysiologicalsignificanceofscaledependentpatternsinprokaryoticgenomesunveiledbyacombinationofstatisticandgenometricanalyses
‡A
Ecophysiological significance of scale-dependent patterns in prokaryotic genomes unveiled by a combination of statistic and genometric analyses
‡9
1
|
919
|
|
|
‡a
empiricalmodelsandhillcoefficients
‡A
Empirical models and Hill coefficients.
‡9
1
|
919
|
|
|
‡a
enhancednoradrenergictransmissioninthespontaneouslyhypertensiveratanococcygeusmuscle
‡A
Enhanced noradrenergic transmission in the spontaneously hypertensive rat anococcygeus muscle
‡9
1
|
919
|
|
|
‡a
evaluationofoperationalmodelsofagonismandallosterismatreceptorswithmultipleorthostericbindingsites
‡A
Evaluation of Operational Models of Agonism and Allosterism at Receptors with Multiple Orthosteric Binding Sites
‡9
1
|
919
|
|
|
‡a
evidencefordistinctantagonistrevealedfunctionalstatesof5hydroxytryptamine
‡A
Evidence for distinct antagonist-revealed functional states of 5-hydroxytryptamine
‡9
1
|
919
|
|
|
‡a
evidencefordistinctantagonistrevealedfunctionalstatesof5hydroxytryptamine2areceptorhomodimers
‡A
Evidence for distinct antagonist-revealed functional states of 5-hydroxytryptamine(2A) receptor homodimers.
‡9
1
|
919
|
|
|
‡a
exploringtheactivationmechanismofthemglu5transmembranedomain
‡A
Exploring the Activation Mechanism of the mGlu5 Transmembrane Domain
‡9
1
|
919
|
|
|
‡a
exploringtheactiveconformationofcyclohexanecarboxylatepositiveallostericmodulatorsofthetype4metabotropicglutamatereceptor
‡A
Exploring the Active Conformation of Cyclohexane Carboxylate Positive Allosteric Modulators of the Type 4 Metabotropic Glutamate Receptor
‡9
1
|
919
|
|
|
‡a
followupgenotoxicstudychromosomedamage2and6yearsafterexposuretotheprestigeoilspill
‡A
Follow-Up Genotoxic Study: Chromosome Damage Two and Six Years after Exposure to the Prestige Oil Spill
‡9
1
|
919
|
|
|
‡a
gnao1encephalopathyfurtherdelineationofasevereneurodevelopmentalsyndromeaffectingfemales
‡A
GNAO1 encephalopathy: further delineation of a severe neurodevelopmental syndrome affecting females.
‡9
1
|
919
|
|
|
‡a
havemanyestimatesofefficacyandaffinitybeenmisledrevisitingtheoperationalmodelofagonism
‡A
Have many estimates of efficacy and affinity been misled? Revisiting the operational model of agonism
‡9
1
|
919
|
|
|
‡a
headcircumferencegrowthfunctionasamarkerofneurologicalimpairmentinacohortofmicrocephalicinfantsandchildren
‡A
Head circumference growth function as a marker of neurological impairment in a cohort of microcephalic infants and children
‡9
1
|
919
|
|
|
‡a
helix3actsasaconformationalhingeinclassagpcractivationananalysisofinterhelicalinteractionenergiesincrystalstructures
‡A
Helix 3 acts as a conformational hinge in Class A GPCR activation: An analysis of interhelical interaction energies in crystal structures
‡9
1
|
919
|
|
|
‡a
howinversecananeutralantagonistbestrategicquestionsaftertherimonabantissue
‡A
How inverse can a neutral antagonist be? Strategic questions after the rimonabant issue
‡9
1
|
919
|
|
|
‡a
illuminatingphenylazopyridinestophotoswitchmetabotropicglutamatereceptorsfromtheflasktotheanimals
‡A
Illuminating Phenylazopyridines To Photoswitch Metabotropic Glutamate Receptors: From the Flask to the Animals
‡9
1
|
919
|
|
|
‡a
increasedsuperoxideanionproductionbyinterleukin1betaimpairsnitricoxidemediatedrelaxationinresistancearteries
‡A
Increased superoxide anion production by interleukin-1beta impairs nitric oxide-mediated relaxation in resistance arteries
‡9
1
|
919
|
|
|
‡a
insightsintoadenosinea2areceptoractivationthroughcooperativemodulationofagonistandallostericlipidinteractions
‡A
Insights into adenosine A2A receptor activation through cooperative modulation of agonist and allosteric lipid interactions
‡9
1
|
919
|
|
|
‡a
integratedsyntheticpharmacologicalandcomputationalinvestigationofcis235dichlorophenylcarbamoylcyclohexanecarboxylicacidenantiomersaspositiveallostericmodulatorsofmetabotropicglutamatereceptorsubtype4
‡A
Integrated synthetic, pharmacological, and computational investigation of cis-2-(3,5-dichlorophenylcarbamoyl)cyclohexanecarboxylic acid enantiomers as positive allosteric modulators of metabotropic glutamate receptor subtype 4.
‡9
1
|
919
|
|
|
‡a
labelnoiseinsubtypediscriminationofclass100gproteincoupledreceptorsasystematicapproachtotheanalysisofclassificationerrors
‡A
Label noise in subtype discrimination of class C G protein-coupled receptors: A systematic approach to the analysis of classification errors
‡9
1
|
919
|
|
|
‡a
mathematicalmodelingofgproteincoupledreceptorfunctionwhatcanwelearnfromempiricalandmechanisticmodels
‡A
Mathematical modeling of G protein-coupled receptor function: what can we learn from empirical and mechanistic models?
‡9
1
|
919
|
|
|
‡a
mechanisticanalysisofthefunctionofagonistsandallostericmodulatorsreconciling2stateandoperationalmodels
‡A
Mechanistic analysis of the function of agonists and allosteric modulators: reconciling two-state and operational models
‡9
1
|
919
|
|
|
‡a
modelingcooperativityeffectsindimericgproteincoupledreceptors
‡A
Modeling cooperativity effects in dimeric G protein-coupled receptors.
‡9
1
|
919
|
|
|
‡a
modelingthebindingandfunctionofmetabotropicglutamatereceptors
‡A
Modeling the binding and function of metabotropic glutamate receptors.
‡9
1
|
919
|
|
|
‡a
modellingthechangesduetotheendotheliumandhypertensioninthealphaadrenoreceptormediatedresponsesofrataorta
‡A
Modelling the changes due to the endothelium and hypertension in the alpha-adrenoreceptor-mediated responses of rat aorta.
‡9
1
|
919
|
|
|
‡a
multipleactivereceptorconformationagonistefficacyandmaximumeffectofthesystemtheconformationbasedoperationalmodelofagonism
‡A
Multiple active receptor conformation, agonist efficacy and maximum effect of the system: the conformation-based operational model of agonism
‡9
1
|
919
|
|
|
‡a
onthefittingofbindingdatawhenreceptordimerizationissuspected
‡A
On the fitting of binding data when receptor dimerization is suspected
‡9
1
|
919
|
|
|
‡a
operationalmodelsofallostericmodulationcautionisneeded
‡A
Operational models of allosteric modulation: caution is needed
‡9
1
|
919
|
|
|
‡a
opticalcontrolofpaininvivowithaphotoactivemglu5receptornegativeallostericmodulator
‡A
Optical control of pain in vivo with a photoactive mGlu5 receptor negative allosteric modulator
‡9
1
|
919
|
|
|
‡a
optoglunam41aphotoswitchableallostericantagonistforrealtimecontrolofmglu4receptoractivity
‡A
OptoGluNAM4.1, a Photoswitchable Allosteric Antagonist for Real-Time Control of mGlu4 Receptor Activity.
‡9
1
|
919
|
|
|
‡a
overlappingbindingsitesdriveallostericagonismandpositivecooperativityintype4metabotropicglutamatereceptors
‡A
Overlapping binding sites drive allosteric agonism and positive cooperativity in type 4 metabotropic glutamate receptors
‡9
1
|
919
|
|
|
‡a
paternalageandnumericalchromosomeabnormalitiesinhumanspermatozoa
‡A
Paternal Age and Numerical Chromosome Abnormalities in Human Spermatozoa
‡9
1
|
919
|
|
|
‡a
persistenceofbreakageinspecificchromosomebands6yearsafteracuteexposuretooil
‡A
Persistence of Breakage in Specific Chromosome Bands 6 Years after Acute Exposure to Oil.
‡9
1
|
919
|
|
|
‡a
pharmacologicalevidenceforametabotropicglutamatereceptorheterodimerinneuronalcells
‡A
Pharmacological evidence for a metabotropic glutamate receptor heterodimer in neuronal cells
‡9
1
|
919
|
|
|
‡a
positionalisomersofbispyridinebenzenederivativesinduceefficacychangesonmglu5negativeallostericmodulation
‡A
Positional isomers of bispyridine benzene derivatives induce efficacy changes on mGlu5 negative allosteric modulation.
‡9
1
|
919
|
|
|
‡a
prefaceincells
‡A
Preface. In cells
‡9
1
|
919
|
|
|
‡a
quantifyingconformationalchangesingpcrsglimpseofacommonfunctionalmechanism
‡A
Quantifying conformational changes in GPCRs: glimpse of a common functional mechanism.
‡9
1
|
919
|
|
|
‡a
quantifyingtheallostericinteractionswithinagproteincoupledreceptorheterodimer
‡A
Quantifying the allosteric interactions within a G-protein-coupled receptor heterodimer
‡9
1
|
919
|
|
|
‡a
rationaldesignofapeptidecaptureagentforcxcl8basedonamodelofthecxcl8cxcr1complex
‡A
Rational design of a peptide capture agent for CXCL8 based on a model of the CXCL8:CXCR1 complex
‡9
1
|
919
|
|
|
‡a
reducingthengramfeaturespaceofclass100gpcrstosubtypediscriminatingpatterns
‡A
Reducing the n-gram feature space of class C GPCRs to subtype-discriminating patterns
‡9
1
|
919
|
|
|
‡a
representationlearningforclass100gproteincoupledreceptorsclassification
‡A
Representation Learning for Class C G Protein-Coupled Receptors Classification
‡9
1
|
919
|
|
|
‡a
revealingthemechanismofagonistmediatedcannabinoidreceptor1cb1activationandphospholipidmediatedallostericmodulation
‡A
Revealing the Mechanism of Agonist-Mediated Cannabinoid Receptor 1 (CB1) Activation and Phospholipid-Mediated Allosteric Modulation
‡9
1
|
919
|
|
|
‡a
roleofelastininspontaneouslyhypertensiveratsmallmesentericarteryremodelling
‡A
Role of elastin in spontaneously hypertensive rat small mesenteric artery remodelling
‡9
1
|
919
|
|
|
‡a
selectiveprotonationofacidicresiduestriggersopsinactivation
‡A
Selective Protonation of Acidic Residues Triggers Opsin Activation
‡9
1
|
919
|
|
|
‡a
shiftinnucleotideconformationalequilibriumcontributestoincreasedrateofcatalysisofgpapversusgpainbarnase
‡A
Shift in nucleotide conformational equilibrium contributes to increased rate of catalysis of GpAp versus GpA in barnase
‡9
1
|
919
|
|
|
‡a
shininglightonanmglu5photoswitchablenamatheoreticalperspective
‡A
Shining Light on an mGlu5 Photoswitchable NAM: A Theoretical Perspective
‡9
1
|
919
|
|
|
‡a
statisticsfortheanalysisofmoleculardynamicssimulationsprovidingpvaluesforagonistdependentgpcractivation
‡A
Statistics for the analysis of molecular dynamics simulations: providing P values for agonist-dependent GPCR activation
‡9
1
|
919
|
|
|
‡a
structuralinsightsintopositiveandnegativeallostericregulationofagproteincoupledreceptorthroughproteinlipidinteractions
‡A
Structural insights into positive and negative allosteric regulation of a G protein-coupled receptor through protein-lipid interactions.
‡9
1
|
919
|
|
|
‡a
synthesistowardbivalentligandsforthedopamined2andmetabotropicglutamate5receptors
‡A
Synthesis toward Bivalent Ligands for the Dopamine D2 and Metabotropic Glutamate 5 Receptors
‡9
1
|
919
|
|
|
‡a
systematicanalysisofprimarysequencedomainsegmentsforthediscriminationbetweenclass100gpcrsubtypes
‡A
Systematic Analysis of Primary Sequence Domain Segments for the Discrimination Between Class C GPCR Subtypes.
‡9
1
|
919
|
|
|
‡a
terminatingevolutionaryalgorithmsattheirsteadystate
‡A
Terminating evolutionary algorithms at their steady state
‡9
1
|
919
|
|
|
‡a
textminingandexpertcurationtodevelopadatabaseonpsychiatricdiseasesandtheirgenes
‡A
Text mining and expert curation to develop a database on psychiatric diseases and their genes
‡9
1
|
919
|
|
|
‡a
asymmetricsymmetricactivationofgpcrdimersasapossiblemechanisticrationaleformultiplesignallingpathways
‡A
The asymmetric/symmetric activation of GPCR dimers as a possible mechanistic rationale for multiple signalling pathways.
‡9
1
|
919
|
|
|
‡a
catalyticpowerofenzymesconformationalselectionortransitionstatestabilization
‡A
The catalytic power of enzymes: conformational selection or transition state stabilization?
‡9
1
|
919
|
|
|
‡a
effectofthemolecularmechanismofgproteincoupledreceptoractivationontheprocessofsignaltransduction
‡A
The effect of the molecular mechanism of G protein-coupled receptor activation on the process of signal transduction
‡9
1
|
919
|
|
|
‡a
influenceofalignmentfreesequencerepresentationsonthesemisupervisedclassificationofclass100gproteincoupledreceptorssemisupervisedclassificationofclass100gpcrs
‡A
The influence of alignment-free sequence representations on the semi-supervised classification of class C G protein-coupled receptors: semi-supervised classification of class C GPCRs.
‡9
1
|
919
|
|
|
‡a
slopeparameterandthereceptorreserve
‡A
The slope parameter and the receptor reserve
‡9
1
|
919
|
|
|
‡a
structureandactivityofmembranereceptorscomputationalsimulationofhistamineh2receptoractivation
‡A
The structure and activity of membrane receptors: computational simulation of histamine H2-receptor activation
‡9
1
|
919
|
|
|
‡a
transientmiddlecerebralarteryocclusioncausesdifferentstructuralmechanicalandmyogenicalterationsinnormotensiveandhypertensiverats
‡A
Transient middle cerebral artery occlusion causes different structural, mechanical, and myogenic alterations in normotensive and hypertensive rats
‡9
1
|
919
|
|
|
‡a
usingmachinelearningtoolsforproteindatabasebiocurationassistance
‡A
Using machine learning tools for protein database biocuration assistance
‡9
1
|
946
|
|
|
‡a
b
‡9
1
|
996
|
|
|
‡2
BNE|XX1705426
|
996
|
|
|
‡2
LC|nb2011028474
|
996
|
|
|
‡2
LC|nr 93050401
|
996
|
|
|
‡2
DNB|1020135751
|
996
|
|
|
‡2
ISNI|0000000381810605
|
996
|
|
|
‡2
SUDOC|151814384
|
996
|
|
|
‡2
SUDOC|255012152
|
996
|
|
|
‡2
RERO|A023414583
|
996
|
|
|
‡2
BIBSYS|90951336
|
996
|
|
|
‡2
ISNI|000000004095044X
|
996
|
|
|
‡2
LC|n 91094847
|
996
|
|
|
‡2
LC|n 2005070933
|
996
|
|
|
‡2
SUDOC|157716856
|
996
|
|
|
‡2
BNE|XX822781
|
996
|
|
|
‡2
ISNI|0000000029703747
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|
998
|
|
|
‡a
Giraldo, Jesús
‡2
BNC|981058519111006706
‡3
standard number
|
998
|
|
|
‡a
Giraldo, Jesús
‡2
ISNI|0000000140182126
‡3
suggested
|
998
|
|
|
‡a
Giraldo, Jesús
‡2
BNE|XX822781
‡3
suggested
|
998
|
|
|
‡a
Giraldo, Jesús
‡2
SUDOC|157716856
‡3
suggested
|
998
|
|
|
‡a
Giraldo, Jesús
‡2
NKC|osd2014849677
‡3
suggested
‡3
standard number
|
998
|
|
|
‡a
Giraldo, Jesús
‡2
LC|nb2011027688
‡3
suggested
|
998
|
|
|
‡a
Giraldo, Jesús
‡2
BIBSYS|90951336
‡3
viafid
|
998
|
|
|
‡a
Giraldo, Jesús
‡2
J9U|987007328379505171
‡3
suggested
|